课题基金 / 基金详情

COMPARE THE PHARMACOKINETICS OF NEORAL TO SANDIMMUNE IN RENAL TRANSPLANT

COMPARE THE PHARMACOKINETICS OF NEORAL TO SANDIMMUNE IN RENAL TRANSPLANT
肾移植中 NEORAL 与 SANDIMUNE 的药代动力学比较
批准号：
5221704
负责人：
ROBERT Bruce ETTENGER
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5221704
关键词：
artificial immunosuppression child (0-11) clinical research clinical trials cyclosporines dosage forms drug screening /evaluation human subject immunosuppressive kidney transplantation oral administration pediatric pharmacology pharmacokinetics

项目摘要

项目成果

ROBERT Bruce ETTENGER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this study is to compare the oral bio-availability of CsA Neoral administered at a 1:1 dose ratio to Sandimmune (SIM) in stable pediatric renal transplant patients and to compare the pharmacokinetics of both these formulations to one another.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
PHASE I/II OPEN-LABEL PHARMACOKINETIC AND SAFETY STUDY OF ZENAPAX